Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.53% | 170.20 | 0.7% | $964.07m | |
| ABBV | AbbVie, Inc. | 1.67% | 140.34 | 1.9% | $841.79m | |
| PFE | Pfizer Inc. | 0.61% | 49.57 | 0.9% | $830.12m | |
| LLY | Eli Lilly & Co. | 0.39% | 302.50 | 1.1% | $749.11m | |
| MRK | Merck & Co., Inc. | 1.24% | 88.49 | 0.7% | $749.03m | |
| BMY | Bristol-Myers Squibb Co. | 2.33% | 73.80 | 1.0% | $664.96m | |
| SIGA | SIGA Technologies, Inc. | -4.76% | 22.19 | 0.0% | $393.19m | |
| AZN | AstraZeneca Plc | -1.38% | 65.12 | 1.0% | $376.21m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5.56% | 230.74 | 8.1% | $254.69m | |
| GSK | GSK Plc | -0.64% | 40.31 | 0.3% | $216.46m | |
| HZNP | Horizon Therapeutics Plc | 0.07% | 69.65 | 5.4% | $197.93m | |
| SGEN | Seagen Inc. | 1.43% | 178.33 | 5.7% | $191.45m | |
| NVS | Novartis AG | 0.43% | 85.94 | 0.2% | $174.13m | |
| RGEN | Repligen Corp. | 1.70% | 250.46 | 6.7% | $158.40m | |
| NVO | Novo Nordisk A/S | -0.76% | 102.42 | 0.1% | $151.74m |
Company Profile
Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.